Vesicular Stomatitis Virus Pseudotyped with Ebola Virus Glycoprotein Serves as a Protective, Noninfectious Vaccine against Ebola Virus Challenge in Mice

The recent Ebola virus (EBOV) epidemic in West Africa demonstrates the potential for a significant public health burden caused by filoviral infections. No vaccine or antiviral is currently FDA approved. To expand the vaccine options potentially available, we assessed protection conferred by an EBOV...

詳細記述

保存先:
書誌詳細
出版年:J Virol
主要な著者: Lennemann, Nicholas J., Herbert, Andrew S., Brouillette, Rachel, Rhein, Bethany, Bakken, Russell A., Perschbacher, Katherine J., Cooney, Ashley L., Miller-Hunt, Catherine L., Ten Eyck, Patrick, Biggins, Julia, Olinger, Gene, Dye, John M., Maury, Wendy
フォーマット: Artigo
言語:Inglês
出版事項: American Society for Microbiology 2017
主題:
Vaccines and Antiviral Agents
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC5553159/
https://ncbi.nlm.nih.gov/pubmed/28615211
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/JVI.00479-17
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料